Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001476010-09-000001
Filing Date
2009-11-05
Accepted
2009-11-05 10:39:18
Documents
1
Effectiveness Date
2009-11-05
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8638
  Complete submission text file 0001476010-09-000001.txt   10148
Mailing Address C/O THIRD ROCK VENTURES, L.P. 29 NEWBURY STREET BOSTON MA 02116
Business Address C/O THIRD ROCK VENTURES, L.P. 29 NEWBURY STREET BOSTON MA 02116 617-585-2000
Afferent Pharmaceuticals, Inc. (Filer) CIK: 0001476010 (see all company filings)

EIN.: 271116683 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-135875 | Film No.: 091159989